The rhesus macaque is widely used as a non-human primate model to study infection and immunity due to the close genetic relationship with humans (~93% average human-macaque sequence identity
1) and the homology between human and rhesus pathogen genomes
2, 3. Indeed, rhesus macaques have been used to study fundamental aspects of immunology, including the development and maintenance of T cell memory
4, immunodominance
5 and the aging immune system
6. There have also been many studies of immune responses in rhesus macaque models of human infections such as human immunodeficiency virus (HIV)
7, influenza virus
8, 9, tuberculosis
10, Epstein-Barr virus (EBV)
11, 12, cytomegalovirus (CMV)
4, 13–15, smallpox
16, measles
17 and severe acute respiratory syndrome (SARS)
18. Furthermore, rhesus macaques have been instrumental in the design and testing of vaccines against infections such as HIV
19 and smallpox
16.
The various roles of T lymphocytes in adaptive immune responses to infection, which include the provision of helper functions to other immune cells and cytolytic control of infected cells, require that T cell populations recognize a large variety of foreign peptides bound to major histocompatibility complex (MHC) molecules. This recognition is facilitated by a diverse repertoire of T cell receptors (TCRs). The TCR repertoires that respond to different peptide-MHC epitopes can vary greatly. Indeed, diversity estimates range from ~10 to >1000 different TCRs responding to a specific epitope
20–23. Moreover, some epitope-specific TCR repertoires can feature biased usage of TCR Vβ (TRBV) or Jβ (TRBJ) genes, or distinct patterns of amino acid usage within the third complementarity-determining region (CDR3)
24. Studies of the TCR repertoire can provide valuable information about the molecular evolution of an immune response and the factors that shape clonotype selection
in vivo25. Furthermore, it is becoming increasingly apparent that the clonotypic structure of an epitope-specific T cell response can have important implications for the immune control of some viral infections. For example, one issue of current debate that has important consequences for the rational design of immunotherapeutic and vaccination strategies
24, 26 is whether a restricted TCR repertoire responding to a highly variable pathogen could be associated with the emergence of viral mutants that escape T cell recognition at this epitope
27–31.
Many studies of T cell immunity in rhesus macaque models of infection have utilized TCR repertoire data to gain additional insights
5, 14, 30, 32–43. In particular, a large number of studies have characterized the TCR repertoires of target CD4
+ T cell populations or CD8
+ T cell populations involved in the control of simian immunodeficiency virus (SIV) in rhesus macaques
5, 30, 32–39, 41–43. Most of these studies have relied on human TCR gene homology to identify V and J gene usage. Although the rhesus macaque TCR Dβ (TRBD) and TRBJ genes have previously been sequenced
44, the TRBV genes were not previously available. Here, we present the TRBV, TRBD and TRBJ genes extracted from the rhesus macaque genome
1 on the basis of their homology with the human TRB genes. In addition, we demonstrate extracted TRB gene usage in expressed TCRβ sequences by using an existing database of 7218 TCRβ sequences involved in CD8
+ T cell responses specific for the immunodominant Mamu-A*01-restricted SL8/TL8 (S/TTPESANL; Tat, residues 28–35) and CM9 (CTPYDINQM; Gag, residues 181–189) epitopes derived from SIV
30, 45. The TRB genes extracted from the rhesus macaque genome will enable more accurate characterization of rhesus macaque TCRβ repertoires.